FLGT Q2 2021 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q2 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$154M+789.8% YoY

Gross Profit

$118M76.7% margin

Operating Income

$99M64.4% margin

Net Income

$80M52.0% margin

EPS (Diluted)

$2.59

QoQ Revenue Growth

-57.3%

Cash Flow

Operating Cash Flow

$76M

Free Cash Flow

$73M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$129M

Stockholders' Equity

$913M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$154M	$17M	+789.8%
Gross Profit	$118M	$10M	+1133.3%
Operating Income	$99M	$3M	+3646.1%
Net Income	$80M	$3M	+2303.3%

Geographic Segments

UNITED STATES

$150M98%

Non Us

$4M2%